China Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Curious about BaaS? Get the full feature comparison in our free eBook comparing the time to create your own cloud backend to a Backend as a Service like Kinvey. From our sponsors

China Pharmaceuticals and Healthcare Report Q4 2013 Sep 18th 2013, 00:00, by swapnil BMI View: While multinational pharmaceutical firms continue to see double-digit sales growth in China, we note that for several firms, expansion of revenue has declined slightly compared with recent quarters. Pricing issues, coupled with the government’s investigation into corruption claims, remain a key concern for companies and their investors. However, we do not expect to see any major shake-ups in the sector given that the enquiry is not due to be completed before November 2013. Headline Expenditure Projections ? Pharmaceuticals: CNY453.2bn (US$71.8bn) in 2012 to CNY532.4bn (US$85.9bn) in 2013; +17.5% in local currency and +19.6% in US dollar terms. Absolute … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116084. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/china-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions